Skip to main content

#156579

Anti-CD134 [OX40]

Cat. #156579

Anti-CD134 [OX40]

Cat. #: 156579

Unit size: 100 ug

Availability: 10-12 weeks

Target: CD134 c

Class: Monoclonal

Application: FACS ; IHC

Reactivity: Rat

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Medical Research Council; University of Oxford

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD134 [OX40]
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Rat
  • Host: Mouse
  • Application: FACS ; IHC
  • Description: The antibody recognises an antigen detected only on rat T blasts that also express the CD4 antigen. The OX-40 antigen is a distinct chain of molecular weight 45-50kDa. OX-40 monoclonal antibody augments T cell proliferation at late stages of in vitro responses.
  • Immunogen: PHA-activated rat lymph node cells
  • Myeloma used: NS1/1
  • Recommended controls: IgG2b

Target Details

  • Target: CD134 c
  • Target background: The antibody recognises an antigen detected only on rat T blasts that also express the CD4 antigen. The OX-40 antigen is a distinct chain of molecular weight 45-50kDa. OX-40 monoclonal antibody augments T cell proliferation at late stages of in vitro responses.

Applications

  • Application: FACS ; IHC

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Paterson et al. 1987. Mol Immunol. 24(12):1281-90. PMID: 2828930.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.